Literature DB >> 3763153

Pathogenesis of cataracts in patients with Lowe's syndrome.

R C Tripathi, G W Cibis, B J Tripathi.   

Abstract

Based on our morphologic and ultrastructural studies, we suggest that the characteristic lens opacities in Lowe's syndrome result from a genetic defect in the lens cells. This defect manifests early in embryogenesis, and the progression of the lens opacities is related to both the inherent genetic abnormality and the prevailing extralenticular environment. The defective formation and subsequent degeneration of the primary posterior lens fibers account for their loss and for the flattened, discoid, or ring-shaped cataract. The other findings, such as anterior polar cataract, subcapsular fibrous plaque, capsular excrescences, bladder cells, and posterior lenticonus are not necessarily specific for Lowe's syndrome. We believe that the pathogenesis of Lowe's cataract can be explained by Lyon's hypothesis, which implies that, very early in embryogenesis (at the stage of the primitive streak), one of the two X chromosomes in females is deactivated. We consider the high incidence of lens opacities in female carriers to be due to this random deactivation. In male probands, however, all lens cells are affected, since there is no normal X chromosome to nullify the effect of the Lowe gene.

Entities:  

Mesh:

Year:  1986        PMID: 3763153     DOI: 10.1016/s0161-6420(86)33622-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  13 in total

1.  Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy.

Authors:  Susan P Bothwell; Emily Chan; Isa M Bernardini; Yien-Ming Kuo; William A Gahl; Robert L Nussbaum
Journal:  J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 10.121

Review 2.  The role of the lens actin cytoskeleton in fiber cell elongation and differentiation.

Authors:  P Vasantha Rao; Rupalatha Maddala
Journal:  Semin Cell Dev Biol       Date:  2006-11-01       Impact factor: 7.727

Review 3.  The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.

Authors:  Maria Antonietta De Matteis; Leopoldo Staiano; Francesco Emma; Olivier Devuyst
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

Review 4.  Congenital and infantile cataract: aetiology and management.

Authors:  Wai H Chan; Susmito Biswas; Jane L Ashworth; I Christopher Lloyd
Journal:  Eur J Pediatr       Date:  2012-03-01       Impact factor: 3.183

5.  Oculocerebrorenal syndrome of Lowe: Survey of ophthalmic presentations and management.

Authors:  Xiaowan Ma; Ke Ning; Sayena Jabbehdari; Philipp P Prosseda; Yang Hu; Ann Shue; Scott R Lambert; Yang Sun
Journal:  Eur J Ophthalmol       Date:  2020-04-27       Impact factor: 2.597

6.  Ascorbic acid and amino acid values in the aqueous humor of a patient with Lowe's syndrome.

Authors:  S Hayasaka; T Yamada; K Nitta; Y Kaji; S Hiraki; K Tachinami; M Matsumoto; S Yamamoto; S Yamamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-04       Impact factor: 3.117

7.  Case Report: Combined Cataract Surgery and Minimally Invasive Glaucoma Surgery Provide an Alternative Treatment Approach for Lowe Syndrome.

Authors:  Chen Wang; Wenzhe Zhang; Leyi Wang; Wenhui Liu; Hui Guo
Journal:  Front Med (Lausanne)       Date:  2022-07-01

8.  [Clinical and genetic results with reference to corneal alterations in Lowe-syndrome].

Authors:  G Rudolph; P Kalpadakis; W Röschinger; C Haritoglou; S Kammerer; K-P Boergen; A Kampik
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

9.  Tightly linked flanking markers for the Lowe oculocerebrorenal syndrome, with application to carrier assessment.

Authors:  D S Reilly; R A Lewis; D H Ledbetter; R L Nussbaum
Journal:  Am J Hum Genet       Date:  1988-05       Impact factor: 11.025

Review 10.  Lowe syndrome.

Authors:  Mario Loi
Journal:  Orphanet J Rare Dis       Date:  2006-05-18       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.